
Conformity Assessment and Notified Body
Once the class of your device is known, the next question is this: which annex will you follow, do you need to go to a notified body for this, and which document will you end up with? This trio
Conformity Assessment Procedures and Notified Body Routes (ÜTS Document Registration)
Once the class of your device is known, the next question is this: which annex will you follow, do you need to go to a notified body for this, and which document will you end up with? This trio also determines which document can be linked to the device in ÜTS; a certificate issued under the wrong annex cannot be linked to the record, because it does not match the device class.
For all five frameworks (MDD, AIMDD, IVDD, MDR and IVDR), this page gives the class-based conformity assessment routes: which annex applies for each class, whether a notified body is involved, and which document business rule operates in ÜTS. The provisions are taken from Articles 58 to 67 of TİTCK's "Guide on the Registration Processes of Medical Devices to the Product Tracking System" (TCKKD-KLVZ-03) and from the Medical Device Regulation. For Class I and Class A devices, no notified body reads the file before the device is placed on the market; if you would like your file to be read independently, see our technical file pre-review and preparation service.
What Is a Conformity Assessment Procedure?
The definitions article of the Guide separates two concepts. The Conformity Assessment Procedure is the process demonstrating whether the requirements of the Regulation that a device falls under have been fulfilled. The Conformity Assessment Body is the body that performs third-party conformity assessment activities, including calibration, testing, certification and inspection.
The obligation belongs to the manufacturer and is fulfilled before the device is placed on the market. Paragraph 2 of Article 61 of the Guide states that, before placing a device on the market, manufacturers carry out an assessment of the conformity of the device in accordance with the relevant conformity assessment procedures set out in Annexes IX to XI of the MDR. Paragraph 2 of Article 62 of the Guide repeats the same provision for Annexes IX to XI of the IVDR.
The obligation does not fall away for devices that are not placed on the market. Paragraph 3 of Article 61 of the Guide states that the same assessment is also carried out before a device that is not placed on the market is put into service. Paragraph 3 of Article 62 of the Guide imposes the same obligation, excluding devices manufactured and used within health institutions under paragraph 5 of Article 6 of the IVDR.
What Is a Notified Body and How Is It Verified from NANDO?
The definitions article of the Guide defines the notified body briefly: a conformity assessment body designated under the Medical Device Regulations. That is, not every conformity assessment body is a notified body; it must have been designated.
The verification process on the ÜTS side is written down. Paragraph 7 of Article 6 of the Guide states that, if the notified body issuing the EC certificate is not defined in ÜTS, before the document registration of the relevant certificate a request is opened through the "Notified/Conformity Assessment Body Transactions" field on the "Submit Request" screen. If, as a result of queries made through the "NANDO Notified Bodies" query site on the basis of the request, it is established that the body is authorised as a notified body under the relevant legislation, the body is added to ÜTS and defined in ÜTS according to the old Medical Device Regulations (MDD, IVDD, AIMDD) under which it is authorised.
Paragraph 7 of Article 7 of the Guide sets up the same flow for EU certificates; there the definition is made according to the new Medical Device Regulations (MDR, IVDR) under which it is authorised. The practical consequence is this: whichever regulation the body's NANDO authorisation covers, it is defined in ÜTS for that regulation; a certificate issued for a regulation outside the scope is not accepted.
Annex E-1: MDD Route Matrix
Article 58 of the Guide regulates the procedures to be followed for devices under the MDD according to the device type and risk class concerned. The document business rules on the ÜTS side are shown, under Article 63 of the Guide, in Annex-81, Annex-82 and Annex-83.
Class I Other: The procedures specified in MDD Annex VII are followed and technical documentation is drawn up as specified in the same annex; the declaration of conformity is then drawn up as referred to in Article 10 of the Guide. No notified body is required. The ÜTS document business rules are in Annex-81.
Class Is (supplied sterile): In addition to Annex VII, one of the procedures specified in MDD Annex II, Annex IV, Annex V or Annex VI is also carried out. The involvement of the notified body in these procedures is limited to the aspects relating to establishing, securing and maintaining sterile conditions.
Class Im (with a measuring function): In addition to Annex VII, one of the same four annexes is carried out. The involvement of the notified body is limited to the aspects relating to the conformity of the devices with the metrological requirements.
Class IIa: Either the declaration of conformity procedure relating to the full quality assurance system in MDD Annex II (excluding Article 4), or the declaration of conformity procedure in MDD Annex VII together with one of the procedures in Annex IV (EC verification), Annex V (production quality assurance) or Annex VI (product quality assurance). The ÜTS document business rules are in Annex-81.
Class IIb: Either MDD Annex II (excluding Article 4), or MDD Annex III type-examination together with one of the procedures in Annex IV, Annex V or Annex VI. The ÜTS document business rules are in Annex-82.
Class III: Either the MDD Annex II full quality assurance system (here Article 4 is not excluded), or MDD Annex III type-examination together with one of the procedures in Annex IV or Annex V. There is no Annex VI route in Class III. The ÜTS document business rules are in Annex-83.
CMD and devices for clinical investigation: Before placing each device on the market, manufacturers follow the procedure in MDD Annex VIII and draw up the declaration specified in the relevant annex. CMDs are placed on the market without bearing the CE marking. The Guide states that, temporarily, only companies and bodies of the "Healthcare Service Provider" type can make a CMD application under the MDD in ÜTS.
SIP (system/procedure pack): SIP manufacturers draw up a manufacturer's declaration (SIP Declaration) as referred to in Article 12 of the MDD and in subparagraph (b) of paragraph 8 of Article 26 of the Guide. If the SIP itself is supplied sterile, it is also subject to one of the procedures specified in MDD Annex II or Annex V; the involvement of the notified body is limited to securing sterility until the sterile pack is opened or damaged. SIPs are placed on the market without an additional CE marking.
Annex E-2: AIMDD Route Matrix
There is no class distinction on the AIMDD side; a single set of routes applies to all devices. Paragraph 3 of Article 64 of the Guide states that all devices under the AIMDD are classified in the same risk group (Class III) as devices classified as Class III under the MDD in ÜTS. The document business rules are shown in Annex-84 under paragraph 4 of the same article.
AIMDD (Class III): Either the declaration of conformity procedure relating to the full quality assurance system specified in AIMDD Annex II, or the EC type-examination specified in AIMDD Annex III together with one of the procedures in Annex IV (EC verification) or Annex V (production quality assurance).
Document combinations in Annex-84: In the full quality assurance route, an EC certificate with the attachment «ANNEX-2 FULL QUALITY ASSURANCE SYSTEM» is required together with an EC certificate with the attachment «ANNEX-2 ARTICLE 4, DESIGN EXAMINATION». In the type-examination route, a certificate with the attachment «ANNEX-3 TYPE EXAMINATION» is required together with a certificate with the attachment «ANNEX-4 EC VERIFICATION» or «ANNEX-5 PRODUCTION QUALITY ASSURANCE».
CMD and devices for clinical investigation: Before placing each device on the market, manufacturers follow the procedure in AIMDD Annex VI and draw up the declaration specified in the relevant annex; these devices are placed on the market without bearing the CE marking. As on the MDD side, temporarily only companies and bodies of the "Healthcare Service Provider" type can make a CMD application under the AIMDD in ÜTS.
Annex E-3: IVDD Route Matrix
Article 60 of the Guide regulates the IVDD side. The ÜTS document business rules are shown, under Article 65, in Annex-85, Annex-86 and Annex-87.
IVD Other: Excluding devices for performance evaluation and those specified in IVDD Annex-II, the manufacturer carries out the procedures specified in IVDD Annex III and draws up technical documentation as specified in the same annex; it then draws up a declaration of conformity as in Article 10 of the Guide. In Annex-85, the only mandatory document for this group is the declaration of conformity with the attachment «ANNEX-3 DECLARATION OF CONFORMITY»; an EC certificate is not required.
Self-Testing Devices: Before drawing up the declaration of conformity, manufacturers also fulfil the other requirements in IVDD Annex III (Article 6 - Design Examination) or carry out one of the procedures prescribed for List-A or List-B. Annex-87 shows the EC certificate with the attachment «ANNEX-3 ARTICLE 6, DESIGN EXAMINATION» and, as an alternative, refers to one of the document registration methods for List-A in Annex-85 and List-B in Annex-86.
Annex-2 List-A: Either the EC Full Quality Assurance System in IVDD Annex IV, or the EC Type-Examination in IVDD Annex V together with the EC Production Quality Assurance in Annex VII. In Annex-85, in the full quality assurance route, a certificate with the attachment «ANNEX-4 ARTICLE 4, DESIGN EXAMINATION» is required together with the certificate with the attachment «ANNEX-4 FULL QUALITY ASSURANCE SYSTEM».
Annex-2 List-B: Either the EC Full Quality Assurance System in IVDD Annex IV (excluding Articles 4 and 6), or the EC Type-Examination in IVDD Annex V together with Annex VI (EC Verification) or Annex VII (EC Production Quality Assurance). The ÜTS document business rules are in Annex-86.
Devices for performance evaluation: Before placing their devices on the market, manufacturers follow the procedure specified in IVDD Annex VIII and draw up the declaration specified in the relevant annex. These devices are placed on the market without bearing the CE marking.
Annex E-4: MDR Route Matrix
Article 61 of the Guide regulates the routes on the MDR side; the ÜTS document business rules are shown in the tables from Annex-88 to Annex-93 under Article 66.
Class I Other: Technical documentation is drawn up as specified in MDR Annex II and Annex III; the EU declaration of conformity is then drawn up as referred to in MDR Annex IV and Article 11 of the Guide. No notified body is required. The document business rules are in Annex-88.
Class Is, Class Im and Class Ir: In addition to the above, one of the procedures specified in MDR Annex IX (Chapters I & III) or MDR Annex XI (Part A) is also carried out. The involvement of the notified body in these procedures is limited to sterility, metrology or reuse aspects.
Class IIa: Either the MDR Annex IX (Chapters I & III) procedure together with the subjecting of at least one representative device for each category of devices to the MDR Annex IX (Chapter II – Section 4) procedure, or the preparation of the technical documentation in Annex II and Annex III accompanied by the conformity assessment specified in MDR Annex XI (Section 10) or Annex XI (Section 18). In the second route the technical documentation assessment is applied to at least one representative device from each category of devices. The document business rules are in Annex-89.
Class IIb Other: Together with MDR Annex IX (Chapters I & III), at least one representative device for each generic device group must be subjected to the technical documentation assessment in MDR Annex IX (Chapter II - Section 4). Alternatively, MDR Annex X type-examination may be applied together with MDR Annex XI (Part A) or Annex XI (Part B) product conformity verification. The document business rules are in Annex-90.
Class IIb implantable devices: For Class IIb implantable devices other than sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectors (WET devices), the technical documentation assessment in MDR Annex IX (Chapter II - Section 4) is applied to every device. The document business rules are in Annex-91.
Class IIb Annex VIII Rule 12 devices: For Class IIb active devices intended to administer and/or remove a medicinal product from the body, referred to in MDR Annex VIII (Section 6.4) and in subparagraph (ç) of paragraph 5 of Article 56 of the Guide, MDR Annex IX (Section 5.1) or MDR Annex X (Section 6) is also applied in addition to the applicable procedures. The document business rules are in Annex-92.
Class III: Either MDR Annex IX (Chapters I & III) together with MDR Annex IX (Chapter II) for every device, or alternatively MDR Annex X type-examination together with MDR Annex XI (Part A) or Annex XI (Part B). For Class III implantable devices, MDR Annex IX (Section 5.1) or Annex X (Section 6) also applies. The document business rules are in Annex-93.
CMD (custom-made devices): Manufacturers follow the procedure specified in MDR Annex XIII and prepare the declaration specified in the relevant annex before placing the devices on the market. Manufacturers of Class III custom-made implantable devices are also subject, in addition to Annex XIII, to a conformity assessment as specified in MDR Annex IX (Chapter I) or MDR Annex XI (Part A). CMDs are placed on the market without bearing the CE marking.
SIP: SIP manufacturers under the MDR draw up a manufacturer's declaration (SIP Declaration) as referred to in Article 22 of the MDR and Article 14 of the Guide. If the SIP is supplied sterile, it is also subject to one of the procedures in MDR Annex IX (Chapters I & III) or Annex XI (Part A); the involvement of the notified body is limited to securing sterility. SIPs are placed on the market without an additional CE marking.
Annex E-5: IVDR Route Matrix
Article 62 of the Guide regulates the IVDR side; the ÜTS document business rules are shown in the tables from Annex-94 to Annex-100 under Article 67.
Class A: Technical documentation is drawn up as specified in IVDR Annex II and Annex III; the EU declaration of conformity is then drawn up as referred to in IVDR Annex IV and Article 11 of the Guide. No notified body is required. The document business rules are in Annex-94.
Class A Sterile: In addition to the above, one of the procedures specified in IVDR Annex IX (Chapters I & III) or IVDR Annex XI is also carried out. The involvement of the notified body in these procedures is limited to the aspects relating to establishing, securing and maintaining sterile conditions.
Class B: Together with the IVDR Annex IX (Chapters I & III) conformity assessment, at least one representative device for each category of devices must be subjected to the IVDR Annex IX (Chapter II – Section 4) procedure; in ÜTS this appears as "Annex IX Chapter II (Excluding Section 5) Technical Documentation Assessment". The document business rules are in Annex-95.
Class C: The IVDR Annex IX (Chapters I & II) conformity assessment is applied together with the technical documentation assessment in IVDR Annex IX (Chapter II – Section 4) of at least one representative device for each generic device group. Alternatively, the manufacturer may choose to apply the assessment in IVDR Annex X together with IVDR Annex XI, excluding its Section 5. The document business rules are in Annex-95.
Class D: Subject to conformity assessment in accordance with IVDR Annex IX (Chapters I & III) and IVDR Annex IX (Chapter II (excluding Section 5)). Alternatively, the assessment in IVDR Annex X may be applied together with the assessment in IVDR Annex XI. The document business rules are in Annex-96.
Self-Testing and Near-Patient Testing devices: Where Class B, Class C and Class D devices are near-patient testing or self-testing devices, the manufacturer also follows the technical documentation assessment procedure specified in IVDR Annex IX (Chapter II – Section 5.1), in addition to the relevant procedures; in ÜTS this appears as "Annex IX Chapter II (Including Section 5)". The document business rules are in Annex-97 for Class B, in Annex-98 for Self-Testing Devices (Class C and D) and in Annex-99 for Near-Patient Testing Devices (Class C and D).
Companion Diagnostic Devices: For Class C, the notified body, in addition to the other procedures, follows the technical documentation assessment procedure in IVDR Annex IX (Chapter II – Section 5.2) for each device and applies the procedure in IVDR Annex IX (Chapter II Section 4.1) to (Chapter II Section 4.8). For Class D too, the notified body additionally carries out consultation under Section 5.2. The document business rules are in Annex-100.
In Which Classes Is a Notified Body Not Required?
A route without a notified body is open in only four places across the five frameworks, and all of them are in the lowest risk group.
MDD: Only Class I Other. Under paragraph 2 of Article 58 of the Guide, the manufacturer carries out Annex VII and draws up a declaration of conformity; the notified body is involved only in Class Is and Class Im, and with a limited scope.
IVDD: Only IVD Other. Under paragraph 2 of Article 60 of the Guide, the manufacturer carries out Annex III and draws up a declaration of conformity.
MDR: Only Class I Other. Under paragraph 4 of Article 61 of the Guide, technical documentation and an EU declaration of conformity under Annex IV are sufficient; in Class Is, Class Im and Class Ir the notified body is involved with a limited scope.
IVDR: Only non-sterile Class A. Under paragraph 4 of Article 62 of the Guide, in Class A Sterile the notified body is involved with a scope limited to sterility.
AIMDD: There is no route without a notified body. Under paragraph 3 of Article 64 of the Guide, all devices under the AIMDD are classified in the Class III risk group, and both routes in Article 59 involve a notified body.
Limited Notified Body Involvement: Sterility, Metrology and Reuse
In the sub-variants of Class I and Class A the notified body becomes involved, but does not assess the whole device. The Guide limits this scope under three headings; the scope of the certificate coincides with this limit.
Sterility: Subparagraph (a) of paragraph 2 of Article 58 and subparagraph (a) of paragraph 4 of Article 61 of the Guide state that, for devices placed on the market in a sterile condition, the involvement of the notified body is limited to the aspects relating to establishing, securing and maintaining sterile conditions. Paragraph 4 of Article 62 of the Guide sets the same limit for IVDR Class A Sterile.
Metrology: Subparagraph (b) of paragraph 2 of Article 58 and subparagraph (b) of paragraph 4 of Article 61 of the Guide state that, for devices with a measuring function, the involvement is limited to the aspects relating to the conformity of the devices with the metrological requirements.
Reuse: Subparagraph (c) of paragraph 4 of Article 61 of the Guide states that, for reusable surgical instruments (Class Ir), the involvement is limited to the aspects relating to the reuse of the device, in particular cleaning, disinfection, sterilisation, maintenance, functional testing and the related instructions for use.
MDR-Specific Additional Procedures: Annex IX Sections 5.1–5.4
In the MDR, certain device characteristics add an additional procedure to the route required by the class. Paragraphs 10 to 13 of Article 61 of the Guide list these four cases; in each, the relevant section of MDR Annex IX, or MDR Annex X (Section 6), applies as appropriate.
Annex IX Section 5.1: For Class III implantable devices and Class IIb active devices under Rule 12 that are intended to administer and/or remove a medicinal product from the body in accordance with MDR Annex VIII (Section 6.4).
Annex IX Section 5.2: For devices incorporating, as an integral part, a substance which, if used separately, may be considered a medicinal product and which has an action ancillary to that of the device; medicinal products derived from human blood or human plasma are also within this scope.
Annex IX Section 5.3: For devices manufactured utilising derivatives of tissues or cells of animal origin that are non-viable or rendered non-viable; devices manufactured utilising derivatives of non-viable human tissues or cells; and devices incorporating, as an integral part, non-viable human tissues, cells or their derivatives that assist the function of the device.
Annex IX Section 5.4: For devices composed of substances or combinations of substances that are intended to be introduced into the human body via a body orifice or applied to the skin and that are absorbed by or locally dispersed in the human body.
IVDR Class D: EU Reference Laboratory and Expert Panel
Class D is the highest risk group of the IVDR, and two additional checks are added to the route. Paragraph 10 of Article 62 of the Guide states that, for devices for which one or more EU reference laboratories have been designated, the notified body carrying out the conformity assessment will request one of these laboratories to verify, by laboratory testing, the performance claimed by the manufacturer and the compliance of the device with the applicable common specifications or with other solutions chosen by the manufacturer to ensure a level of safety and performance at least equivalent, as set out in point 4.9 of IVDR Annex IX or point 3(h) of Annex X. The same paragraph states that these tests focus in particular on analytical and diagnostic sensitivity, using the best available reference materials.
The second check is consultation of the expert panel. Paragraph 11 of Article 62 of the Guide states that, where there are no common specifications for Class D devices and this is the first certification for that type of device, the notified body consults the relevant experts in the expert panels established by the Commission on the manufacturer's performance evaluation report. The paragraph states that, for this purpose, the notified body submits the manufacturer's performance evaluation report to the expert panel within 5 days of receiving it. This 5 days is a transmission period that the legislation gives to the notified body; it does not show how long the process will take.
Mandatory Consultation for Companion Diagnostic Devices
For companion diagnostic devices the notified body does not decide alone. Subparagraph (c) of paragraph 6 of Article 62 of the Guide states that, for Class C devices that are companion diagnostic devices, the notified body consults the Agency and/or one of the competent authorities designated by the EU member states in the field of medicinal products for human use, or the EMA, in accordance with the procedure in IVDR Annex IX (Chapter II Section 5.2). Paragraph 8 of the same article states that, for Class D devices that are companion diagnostic devices, the notified body also consults in addition, under the same procedure.
The consultation obligation does not fall away when an alternative route is chosen either. Paragraph 7 of Article 62 of the Guide states that, when the Annex X route is preferred, the notified body consults the same authorities, in particular for each device, under the procedure specified in point 3(ı) of IVDR Annex X. Paragraph 9 states that, when Annex X and Annex XI are preferred together for Class D, the same consultation is carried out for companion diagnostic devices.
The "Attached" Label: The Certificate Must Match the Device Class
In ÜTS a document is held with three labels: the class of the device, the regulation it belongs to and the annex followed. Paragraph 2 of Article 6 of the Guide lists, among the fields that must be on an EC certificate, the "information on the regulation to which it belongs" and the "information on the annex followed"; paragraph 2 of Article 7 lists the same fields for EU certificates and defines the annex information as "a reference to the relevant annex under which the conformity assessment was carried out". Both articles state that the information entered into ÜTS and the information on the certificate must be the same.
These three labels of the document to be linked to the device must match one of the permitted combinations. Paragraph 2 of Article 63 of the Guide for the MDD, paragraph 2 of Article 66 for the MDR and paragraph 2 of Article 67 for the IVDR set the same provision: the association is carried out in ÜTS according to the document business rules determined by the type and risk class of the relevant device and on the basis of the relevant conformity assessment procedures.
Type-Examination Alone Is Not Enough
There is a recurring pattern in the tables from Annex-83 to Annex-93: a type-examination certificate is always requested together with a second certificate.
MDD Class III: According to Annex-83, an EC certificate with the attachment «ANNEX-3 TYPE EXAMINATION» is required together with an EC certificate with the attachment «ANNEX-4 EC VERIFICATION» or «ANNEX-5 PRODUCTION QUALITY ASSURANCE».
MDD Class III full quality assurance route: According to Annex-83, an EC certificate with the attachment «ANNEX-2 FULL QUALITY ASSURANCE SYSTEM» is required together with an EC certificate with the attachment «ANNEX-2 ARTICLE 4, DESIGN EXAMINATION».
MDR: In the tables from Annex-89 to Annex-93, an EU certificate with the attachment «ANNEX-X TYPE EXAMINATION» is requested together with an EU certificate with the attachment «ANNEX XI (PART A) PRODUCTION QUALITY ASSURANCE» or «ANNEX XI (PART B) PRODUCT VERIFICATION».
The "Including Section 5" and "Excluding Section 5" Distinction
Technical documentation assessment certificates on the IVDR side are held in two variants, and the variant is determined by the way the device is used.
Excluding Section 5: Annex-95 and Annex-96 show, for Class B, Class C and Class D, an EU certificate with the attachment «ANNEX IX CHAPTER II (EXCLUDING SECTION 5) TECHNICAL DOCUMENTATION ASSESSMENT».
Including Section 5: In Annex-97, Annex-98, Annex-99 and Annex-100, an EU certificate with the attachment «ANNEX IX CHAPTER II (INCLUDING SECTION 5) TECHNICAL DOCUMENTATION ASSESSMENT» is requested for self-testing, near-patient testing and companion diagnostic devices.
The "Will Become Mandatory in the Future" Note in Annex-91
There is a phrase in the annexes of the Guide that appears in only one place and is easily overlooked. Annex-91 shows the document business rules for Class IIb implantable devices under the MDR (excluding sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectors). In this table an EU certificate with the attachment «ANNEX IX (CHAPTER II) TECHNICAL DOCUMENTATION ASSESSMENT» is marked with the wording "(optional) (Will Become Mandatory in the Future)".
That this wording appears only in this table can be verified from the source. In Annex-89 and Annex-90 the same certificate is shown with only "(optional)"; in Annex-92 and Annex-93 the "(optional)" wording is not present at all. This distinction means that, for Class IIb implantable devices, the Guide marks that the technical documentation assessment certificate, although it appears optional today, will become mandatory in the future.
Certificate Validity Period and Change of Notified Body
The validity period of a certificate varies by document type, and the ÜTS registration is tied to this period.
EC certificates: Paragraph 3 of Article 6 of the Guide states that, except for the EC Verification Certificate and the EC Type Verification Certificate, EC certificates under the old Medical Device Regulations have a validity period and that this period cannot exceed 5 years. On the basis of re-assessment upon the manufacturer's application, the validity may be extended for additional periods, each not exceeding 5 years; any supplement to a certificate remains valid for as long as the certificate to which it is added is valid.
EU certificates: Paragraph 3 of Article 7 of the Guide states that EU certificates issued under the new Medical Device Regulations remain valid for the period indicated on the certificate, not exceeding 5 years, as long as no change or update is made to the certificate during this period. Extension is likewise made for additional periods, each not exceeding 5 years.
Ban on parallel applications: Paragraph 1 of Article 53 of the Medical Device Regulation states that, where the involvement of a notified body in the conformity assessment procedure is required, the manufacturer may apply to a notified body of its choice, provided it has been designated for the relevant device types; however, it cannot lodge an application in parallel with another notified body for the same conformity assessment procedure.
Voluntary change of notified body: Article 58 of the Medical Device Regulation regulates cases where a manufacturer terminates its contract with a notified body and concludes a contract with another body for the same device. Detailed arrangements are clearly defined in an agreement between the manufacturer, the new notified body and, where applicable, the previous notified body. The agreement covers at minimum the date on which the previous certificates become invalid, the date until which the identification number of the previous body may be displayed, the transfer of documents, the date after which the tasks are assigned to the new body, and the last serial or lot number for which the previous body is responsible.
Cells That Could Not Be Read in the Source Tables
The document combinations given on this page are based on cells that could be read from the annex tables of the Guide. Because the text layer could not be read in four tables, the full labelled document combination for those classes could not be verified from the source.
Annex-81 (MDD Class I Other / Class Is / Class Im / Class IIa): A part of the table cannot be read in the text layer of the source.
Annex-82 (MDD Class IIb): A part of the mandatory document columns cannot be read.
Annex-88 (MDR Class I Other / Class Is / Class Im / Class Ir): The mandatory document columns cannot be read.
Annex-94 (IVDR Class A / Class A Sterile): The mandatory document columns cannot be read.
For these four tables, only the procedural provisions written in Articles 58, 61 and 62 of the Guide are given on this page; the label combinations in the table cells have not been completed by guesswork. For the relevant classes, the labels of the document to be linked to the device should be verified on the current screen in ÜTS.
The route is chosen once, and it then determines both the scope of the certificate and the whole of the ÜTS registration. Companies can also carry out this assessment by opening user authorisation for a consultant from their own ÜTS company pages; the consultant creates the document records and associates them with the device with the "Medical Device Registration Officer" authorisation, and the person who signs the application remains the company's signatory.
If you also place your device on the EU market, you can look at our English guide on notified bodies under the MDR.
